Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1452 (17 June), doi:10.1136/bmj.332.7555.1452
| The first 150 words of the full text of this article appear below. |
EDITORIn their editorial on life without COX 2 inhibitors Shaughnessy and Gordon give examples of drug and non-drug measures shown to be effective in osteoarthritis, but their discussion of opioids was not referenced.1 The omission of studies supporting the use of opioids was surprising, particularly when references for the non-drug measures were included even when the effect sizes were small or the data limited by small numbers.
Two systematic reviews of opioids in chronic non-cancer pain report several papers showing efficacy of opioids (morphine and oxycodone) in osteoarthritis, with an average reduction in pain intensity of 30%, generally considered to be clinically meaningful.2 3 While Kalso et al note the worries of addiction and drug diversion (presumably the reason they are referred to as "a last pharmacological resort" by Shaughnessy and Gordon) and caution that not all patients respond to opioids, Kalso noted in a BMJ editorial in 2005
Colette M Reid, specialist registrar in palliative medicine
Department of Palliative Medicine, Bristol Haematology and Oncology Centre, Bristol BS2 8ED colette.reid@bristol.ac.uk
Jeremy Horwood, research associate
MRC Health Services Research Collaboration, Department of Social Medicine, University of Bristol, Canynge Hall, Bristol BS8 2PR